4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001193125-25-324991
Options or other derivatives
- Director acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Lucera Erick · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-16 | Grant or award : show line 1 in the form Stock option (right to buy) | +150,000 | 150,000 | D |
Loading xslF345X05/ownership.xml…